EXOCHAIN

EXOCHAIN

Created using Figma
Created using Figma
EXOCHAIN The integrity of the established identity is evaluated and maintained by EXOCHAIN's Odentity (TM) framework that provides an indication for evaluating the entity's identity establishment. By enabling users to specify access permissions for accessing data, it is easy to programmatically release data to humans and machines. EXOCHAIN reduces the time and cost required to establish a cautious online interaction that keeps the legal position. When applied as the first use case to the world of clinical research and precision medical care, the LYNK protocol addresses data maintenance and transaction inefficiencies, facilitates democratic access to participation in clinical trials, and then precision Catalyzes the advancement of medical care.
Aug 1, 2018
Sep 30, 2018
100% completed
Raised funds - no Data
past
Token Details
Accepted Currencies
ETH
Company Details
Registered Country
USA
Additional Details
KYC
Yes
Categories
Platform

About EXOCHAIN

We describe a blockchain protocol that provides individuals, organizations and machines (“Entity(ies”)  the ability to form a strong, verified digital identity, and  mechanisms to control the seamless release of verified personal data to third parties. The LYNKTM protocol’s first application is intended to make it easier to share medical record data with healthcare professionals and medical research organizations. The integrity of one’s established identity is evaluated and maintained through EXOCHAIN’s OdentityTM framework, which provides metrics for scoring an Entity’s identity establishment. In conjunction with an interface that allows users to designate permissions for accessing their data, which facilitates the programmatic release of data to humans and machines, EXOCHAIN reduces the time and costs required to establish prudent online interactions that possess legal standing. The LYNK protocol, when applied to the world of clinical research and precision medicine as a first use case, addresses data maintenance and transactional inefficiencies, facilitates democratized access to clinical trial participation, and subsequently catalyzes advancements in precision medicine.

EXOCHAIN Roadmap

  • Q2 2017

  • Market Research.
    Technical Feasibility Assessment.
    Team Setup.
  • Q3 2017

  • Angel Investment.
    Establish Securely Guarded Facility.
    Hire Key Advisors and Contractors.
  • Q4 2017

  • Friends and Family.
    Discounted Presale.
    Establish Board of Directors.
    Close Exclusive Market Access.
    Contracts.
    Release Focused White Paper.
    Trademark Applications.
    SDLC Development.
    DEVOPS Environment Setup.
  • Q1 2018

  • Convert Contractors to Employees.
    Commence MVP Development.
    21CFR Part 11 Audit.
    BlueCloud featured on Fox Business.
    Network, 60M households (2/8 & 2/11).
    Token Pre-sale.
    Smart Contracts.
    Security Audit.
    Patent Applications.
    BlueCloud Mobile App Public Alpha.
  • Read More
  • Q2 2018

  • Public Beta.
    Testnet Integration.
    dApp Smart Contracts.
    dApp Servers.
    dApp Security Audits.
    Mainnet Integration.
    Third-party Login Verification.
    Identity Adjudication & Scoring.
    Contractually Legal Jurisdictional Standing.
  • Q3 2018

  • Token Public-sale.
    Wallet Management & Reporting.
    Know Your Customer Social.
    Graph Connectivity.
  • Q4 2018

  • Key Recovery, Escrow, and PACE Stewards.
    Mobile Transaction Alerting & Management.
    Seamless Release Authority.
    Personal Medical Record Custody.
  • 2019

  • Medical Network Query Analysis.
    Machine Learned Metadata.
    Enhancement.

Activity

Posts:
55
LOW
Followers:
290
VERY LOW
Likes:
282
VERY LOW
Followers:
230
VERY LOW
Tweets:
153
MEDIUM
Alexa
Rank:
5 404 306
VERY LOW
Delta:
1 276 772

Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Chief Operating Officer
unverified
Ralph Seferian
Chief Revenue Officer
unverified
Senior Project Manager
unverified
Director of Human Resources
unverified
Administrative Assistant
unverified
Technical Account Manager
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

U.S. Army Co-Founder
unverified

Last News

  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO